Leveraging collaboration in molecular pathology and skin cancer diagnostics

Leveraging collaboration in molecular pathology and skin cancer diagnostics

April 19, 2016

Trajan Scientific and Medical (Trajan) and the University of Melbourne have embarked on an investigative collaboration today in the fields of molecular pathology and skin cancer diagnostics.

Molecular testing techniques can be used to pursue more accurate cancer screening and disease diagnosis.

Trajan’s emerging tools in micro sampling, sample preparation and mass spectrometry interfaces have generated strong interest in these healthcare applications.

Eight Master of Biotechnology students from the University’s Faculty of Science will be undertaking two industry projects in these areas, with guidance from Trajan mentors Mr Paul Romeo, General Manager, Australia and New Zealand, and Mr Stephen Tomisich, Chief Executive Officer.

"We look forward to fresh insights from the teams, which will help shape Trajan’s roadmap for diagnostic technologies.” said Mr Tomisich.

Academic and industry partnerships are key to Trajan’s collaborative model for innovation, accelerating delivery of scientific and medical solutions to the market that will make a positive impact on human wellbeing.


Photo (L-R): The University of Melbourne student teams at Trajan Global Headquarters in Melbourne, Australia. Paul Romeo (General Manager, Australia and New Zealand, Trajan), Keerthi Kalyan Kothapally, Seumas Shu Men Teh, Angela Tomisich (General Manager, Microscopy Products, Trajan), Robert Lyon (Head of Corporate Development, Trajan), Elpis Barons (General Manager, Accelerator Group, Trajan), Fiona Simpson (Careers and Industry Consultant, The University of Melbourne), Dr Andrew Gooley (Chief Scientific Officer, Trajan), Benjamin Nicholas Le Couteur, Belinda Bich Thuy Thieu Quang, Yanling Wu, Kairui Li, Jie Dong, Jingran Zhang, Rhonda Gailey (Assistant Manager, Corporate Development, Trajan), Dr Matthew Digby (Subject Coordinator, The University of Melbourne), Stephen Tomisich (Chief Executive Officer, Trajan).

More information
Research
The University of Melbourne




Also in News

Photo technique to support better wound care outcomes
Photo technique to support better wound care outcomes

July 31, 2018

A new technique for photographing wounds that could provide more information to support wound care in people with leg wounds is being investigated in a project funded by Trajan Scientific and Medical.

 

Read More

Updated privacy policy - GDPR
Updated privacy policy - GDPR

May 24, 2018

We are committed to protecting and safeguarding your personal data. We now meet the high standard for data privacy introduced by the new European data protection law known as the General Data Protection Regulation (GDPR) effective 25 May 2018.

Read More

The missing link in laboratory automation
The missing link in laboratory automation

April 17, 2018

Trajan is delighted to announce the CHRONECT® Bionic together with Axel Semrau®, METTLER TOLEDO GmbH and Jüke Systemtechnik GmbH. CHRONECT® Bionic automates both time consuming and unpleasant working steps, improving precision and reducing sources of error in sample preparation, leaving laboratory staff more time for other work. CHRONECT® Bionic closes the gap in any laboratory and is available in different variants. For European customers, point of contact is Axel Semrau®. Trajan Scientific and Medical is responsible for North America. 

Read More